AFG
REGN icon

Atomi Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Atomi Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Buy
1,811
+135
+8% +$103K 0.04% 330
2025
Q4 		$1.29M Buy
1,676
+686
+69% +$466K 0.04% 330
2025
Q3 		$557K Buy
+990
New +$560K 0.02% 610
2025
Q2 		– Sell
-725
Closed -$460K – 1164
2025
Q1 		$460K Buy
725
+110
+18% +$75.7K 0.02% 572
2024
Q4 		$438K Buy
615
+40
+7% +$33.6K 0.02% 531
2024
Q3 		$605K Buy
575
+27
+5% +$30K 0.04% 385
2024
Q2 		$576K Buy
548
+166
+43% +$161K 0.04% 351
2024
Q1 		$368K Buy
382
+55
+17% +$52.3K 0.03% 453
2023
Q4 		$287K Buy
+327
New +$269K 0.04% 429

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Atomi Financial Group's REGN Position: Q1 2026 in Review

Atomi Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 8.1% in Q1 2026, buying an estimated $103K and bringing the position to 1,811 shares worth $1.4M. The position accounts for 0.04% of the portfolio, ranked #330.

Atomi Financial Group first reported a position in REGN in Q4 2023 and has held it in 9 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Atomi Financial Group held 1,811 shares of Regeneron Pharmaceuticals worth $1.4M as of Q1 2026.
  • Atomi Financial Group bought 135 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $103K.
  • Regeneron Pharmaceuticals made up 0.04% of Atomi Financial Group's portfolio in Q1 2026, its #330 holding.
  • Atomi Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.